MALAT1 and prostate cancer: Similar observations have been reported in CRC, esophageal carcinoma, gallbladder, cervical cancer, and prostate cancer where knockdown of MALAT1 abrogated tumor growth and/or metastasis in the respective cell line-derived models and/or PDX mouse models [69,87,106,107,108,109].